Aggrenox MDL Nears End As Drug Cos. Reach Final Deal
Teva Pharmaceutical and Boehringer Ingelheim on Monday announced a settlement with the last remaining party accusing them of entering into an illegal pay-for-delay agreement to keep a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article